Concepedia

Piotr Sawrycki

PS

Statistics

Publications

15

Citations

1.8K

H-Index

13

Active since

2012

Affiliations

Provincial Polyclinical Hospital in Toruń(Current)

Dana-Farber Cancer Institute

Samsung Medical Center

Ulsan College

Asan Medical Center

Piotr Sawrycki is an author at Provincial Polyclinical Hospital in Toruń specializing in medicine, oncology, and cancer immunotherapy.

Publications per year

2012–2024

15

Publications

15

Adjuvant Pembrolizumab after Nephrectomy in Renal-Cell Carcinoma

Toni K. Choueiri, Piotr Tomczak, Se Hoon Park et al. · New England Journal of Medicine · 2021 · 746 citations · Full text

, , +13

Overall Survival with Adjuvant Pembrolizumab in Renal-Cell Carcinoma

Toni K. Choueiri, Piotr Tomczak, Se Hoon Park et al. · New England Journal of Medicine · 2024 · 285 citations · Full text

, , +17

Pembrolizumab versus placebo as post-nephrectomy adjuvant therapy for clear cell renal cell carcinoma (KEYNOTE-564): 30-month follow-up analysis of a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

Thomas Powles, Piotr Tomczak, Se Hoon Park et al. · The Lancet Oncology · 2022 · 278 citations · Full text

, , +16

Myelopreservation with the CDK4/6 inhibitor trilaciclib in patients with small-cell lung cancer receiving first-line chemotherapy: a phase Ib/randomized phase II trial

Tibor Csőszi, Marina Maglakelidze, Robert J. Hoyer et al. · Annals of Oncology · 2019 · 169 citations · Full text

, , +16

Alisertib in Combination With Weekly Paclitaxel in Patients With Advanced Breast Cancer or Recurrent Ovarian Cancer

Gerald S. Falchook, Robert L. Coleman, A. Roszak et al. · JAMA Oncology · 2018 · 90 citations · Full text

, , +16

1–5 of 15